-
Study aim
-
Comparison of the effectiveness of 5-fluorouracil ointment 5% and calcipotriol ointment 50 micrograms in the treatment of genital warts
-
Design
-
A clinical trial without a control group, community-based and practice-oriented, parallel groups, double-blind, randomized, phase 2 on 60 patients (30 people receiving 5-fluorouracil 5% and 30 people receiving calcipotriol 50 micrograms) . A simple randomization method was used for randomization.
-
Settings and conduct
-
To investigate the effectiveness of 5% 5-fluorouracil ointment in genital warts and compare its effect with calcipotriol 50 micrograms, patients diagnosed with genital warts who refer to the skin clinic of Imam Khomeini Hospital, Ahvaz, are randomly divided into two groups. The first group will receive 5% 5-fluorouracil ointment and the second group will receive 50 micrograms of calcipotriol. Then, after 1 month of treatment, the effect of the drug is measured through a clinical examination. Also, the study is conducted in a double-blind manner (patient and interventionist) so that the medicine in the same container will be given to the patients by a non-interventionist.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patients who are diagnosed with genital warts for the first time or who have not received genital warts treatment in the last three months, and do not have any other skin disease.
Exclusion criteria: patients with immune system dysfunction, with a previous history of allergy to the study drugs, and pregnant and lactating women.
-
Intervention groups
-
Receiving 5% 5-fluorouracil ointment (n=30) and calcipotriol ointment 50 micrograms (n=30) three times a week for one month
-
Main outcome variables
-
The location and size of the lesion, and the number of genital warts